A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ACR / aclarubicin

[Related PubMed/MEDLINE]
Total Number of Papers: 49
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ACR  (>> Co-occurring Abbreviation)
Long Form:   aclarubicin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 [The efficacy and safety of the patients of myelodysplastic syndromes-refractory anemia with excess blasts treated with decitabine alone or CAG/HAG regimen]. Ara-C, HHT, MDS-REAB, ORR, OS
2012 Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation. DOX, DR5, TRAIL
2008 [Mechanism of CAG regimen eliminating T-cell acute lymphoblastic leukemia A3 cell line]. T-ALL
2006 Aclarubicin plus behenoyl cytarabine and prednisolone for previously treated acute myeloid leukemia patients. AML, BHAC, PSL
2006 Investigation into the ability of the Salmonella umu test to detect DNA damage using antitumor drugs. ---
2001 Long-term follow-up of the clinical efficacy of chemotherapy for acute myeloid leukemia at a single institute. 6-MP, AML, ATRA, BHAC, CR, DFS, DNR, IDA, MIT, OS, PSL
2001 [The cytotoxic effect of a low density lipoprotein delivered aclarubicin on leukemia cells]. LDL
2000 Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor. G-CSF, MDS
2000 In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs. 5-FU, ACD, PPC
10  2000 Inhibitory effects of aclarubicin on nitric oxide production in aortic smooth muscle cells and macrophages. iNOS, NO, RASMCs
11  2000 Priming effects of macrophage colony-stimulating factor on monocytic leukemia cells in combination with chemotherapy: induction of programmed cell death in vivo. M-CSF
12  1998 Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells. ds
13  1998 Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation. DOX
14  1997 Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML. AML, CT, DFS, DNR, SIR
15  1997 [Visualising lymph nodes by aclarubicin bound to activated carbon particles in breast cancer surgery]. ---
16  1995 In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. ALL, DNR, DOX, IDR, MIT
17  1995 [Experimental study and clinical application of a new combination chemotherapy with cis-platinum, adriamycin and carboquone in patients with advanced prostate cancer]. ADM, CQ, IFM, PAA, PD, PEP, PR, VCR
18  1995 [Trial of a treatment for lymph node metastases in patients with breast cancer using aclarubicin bound to activated carbon particles]. ---
19  1994 Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells. DOX, FLC
20  1993 Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia. DNR, DX, IDA
21  1993 Evaluation of oral aclarubicin treatment for tumors of the gastrointestinal track. ---
22  1993 Portal vein infusion of cancer chemotherapeutic agent emulsified with Lipiodol in regenerating liver after partial hepatectomy in rats. Lp
23  1993 Synergistic effects of hyperthermia and intratumorous injection of anti-cancer drugs. ER, ERs, i.p, i.t, PEP
24  1993 [Refractory acute myelogenous leukemia successfully treated with a continuous infusion chemotherapy of low dose aclarubicin and cytosine arabinoside: a case report]. CR
25  1992 Inhibition of different steps of the ubiquitin system by cisplatin and aclarubicin. ---
26  1992 [Pharmacokinetics and action mechanism of anthracyclines]. DNR, DOX, IDA, THP
27  1991 Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark. AML, CR, DNR
28  1991 Inhibitory effect of rat immunization with tularemia vaccine on the in vivo clastogenicity of 4 anthracycline antibiotics. AC, ADR, CA, EADR, TLV
29  1991 Low-dose aclarubicin in blastic transformation of essential thrombocythemia. ET
30  1991 [Enhancement of selective drug accumulation and retention in normal and regenerating liver by the use of lipiodol in portal venous infusion in rats]. Lp
31  1990 New cisplatin schedule in combination with aclarubicin (ACR) with high response rate in recurrent gynecological adenocarcinomas. ---
32  1990 Treatment of myelodysplastic syndrome and atypical leukemia with low-dose aclarubicin. CR, MDS, RA
33  1989 Targeted and sustained delivery of aclarubicin to lymphatics by lactic acid-oligomer microsphere in rat. MS, MW
34  1989 [A clinical study of the radiosensitization of aclarubicin]. ---
35  1989 [Chemotherapy of adult ANLL]. ANLL, CR, DNR
36  1989 [The combined effect of cisplatin and aclarubicin on human lymphocytes in vitro]. ---
37  1987 [Combination chemotherapy with aclarubicin and cisplatinum against malignant intracranial tumor--an in vitro study]. ---
38  1986 Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia. CR
39  1986 Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma. ---
40  1986 [Studies on hematological diseases in elderly patients. Part 4: Chemotherapeutic effect of aclarubicin (ACR) on acute nonlymphocytic leukemia in the aged]. ---
41  1985 Clinical review of aclacinomycin A in Japan. ---
42  1985 [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)]. ---
43  1984 Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. CR
44  1984 Aclarubicin in the treatment of multiple myeloma. ---
45  1984 [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic]. ADM, APD, MCR
46  1983 [Clinical responses and side effects of aclarubicin (ACR) in the treatment of multiple myeloma]. ---
47  1983 [Mechanism of action and resistance of antineoplastic agents]. ADM, BLM, TATA
48  1983 [Study of new antineoplastic antibiotics based on newly discovered action mechanisms]. ADM, APD, BLM, COTC
49  1982 Treatment of relapsed acute myelocytic leukemia with a combination of aclarubicin and cytosine arabinoside. ---